Search for Clinical Trial Results
Neoplasms, Cystic, Mucinous, and Serous - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas Condition: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC) Date: 2016-04-22 Interventions:
|
Recruiting |
Study Name: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma Condition: HER2/Neu+ Uterine Serous Carcinoma Date: 2015-07-02 Interventions: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28 |
Active, not recruiting |
Study Name: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer Condition:
Date: 2007-10-22 Interventions: |
Recruiting |
Study Name: Gastrointestinal Microbiome Study of Appendiceal Cancer Condition:
|
Recruiting |
Study Name: Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin Condition:
Date: 2015-01-19 Interventions: Drug: PrevPac (Prevacid, Amoxicillin, Clarithromycin) 30mg Prevacid, 1g amoxicillin, 500mg clarithromyci |
Recruiting |
Study Name: Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions Condition:
|
Active, not recruiting |
Study Name: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition:
|
Terminated |
Study Name: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm Condition:
Interventions: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr |
Completed |
Study Name: Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition:
|